Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Marginal Bone Loss After Immediate Implant Placement in Esthetic Zone Without Xenograft.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03397316
Recruitment Status : Recruiting
First Posted : January 12, 2018
Last Update Posted : January 17, 2018
Sponsor:
Information provided by (Responsible Party):
Ahmed Alaa Eldin Mohamed, Cairo University

Brief Summary:

Marginal bone loss in immediate implant placement in upper esthetic zone by comparing between non grafting in immediate implant placement with xenograft placement in other side.

the study is to assess the marginal bone loss in the two techniques and compare results between them.


Condition or disease Intervention/treatment Phase
Bone Loss Procedure: xenograft placement . Not Applicable

Detailed Description:

Marginal bone loss in immediate implant placement in upper esthetic zone by comparing between non grafting in immediate implant placement with xenograft placement in other side.

the study is to assess the marginal bone loss in the two techniques and compare results between them after follow up period of 4 months.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 8 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description: Each patient will be given a code by researcher (A.A) and the observers will be blind to which group this case belong.
Primary Purpose: Other
Official Title: Evaluation of Marginal Bone Loss After Immediate Implant Placement in Maxillary Esthetic Zone With and Without Xenograft.
Actual Study Start Date : July 1, 2017
Estimated Primary Completion Date : March 15, 2018
Estimated Study Completion Date : April 1, 2018

Arm Intervention/treatment
No Intervention: Marginal bone loss without grafting.
immediate implant placement in upper esthetic zone.
Active Comparator: marginal bone loss with xenograft.
xenograft placement (Geistlich Bio-Oss) in immediate implant placement in upper esthetic zone between the residual labial bone and implant surface.
Procedure: xenograft placement .
immediate implant placement in upper esthetic zone with xenograft placement between residual labial bone and implant surface.




Primary Outcome Measures :
  1. marginal bone loss [ Time Frame: 4 months ]
    Evaluation of marginal bone loss after Immediate implant placement in maxillary esthetic zone with and without xenograft


Secondary Outcome Measures :
  1. patient satisfaction [ Time Frame: 4 months ]
    measure patient satisfaction by patient satisfaction chart.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adult patients with badly broken teeth in upper esthetic zone indicated for extraction presence of at least 4 mm of bone beyond root apex

Exclusion Criteria:

  • presence of fenestrations or dehiscences of the residual bony walls after extraction heavy smokers more than 20 cigarettes per day. systemic diseases that may affect normal healing. psychiatric problems.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03397316


Locations
Layout table for location information
Egypt
Cairo University Recruiting
Cairo, Egypt, 02
Contact: info@dentistry.cu.edu.eg info@dentistry.cu.edu.eg    0023634965    info@dentistry.cu.edu.eg   
Principal Investigator: Ahmed Alaa         
Sponsors and Collaborators
Cairo University

Layout table for additonal information
Responsible Party: Ahmed Alaa Eldin Mohamed, principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT03397316     History of Changes
Other Study ID Numbers: AlaaCUImplant
First Posted: January 12, 2018    Key Record Dates
Last Update Posted: January 17, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ahmed Alaa Eldin Mohamed, Cairo University:
immediate implant
upper esthetic zone
marginal bone loss

Additional relevant MeSH terms:
Layout table for MeSH terms
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases